RP2 Antikörper (AA 1-350)
Kurzübersicht für RP2 Antikörper (AA 1-350) (ABIN2353394)
Target
Alle RP2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-350
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- RP2 (Protein XRP2, KIAA0215)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- Full length human RP2, aa1-350 (AAH43348.1).
-
Isotyp
- IgG
-
-
anti-Retinitis Pigmentosa 2 (X-Linked Recessive) (RP2) (AA 251-350) antibody
RP2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 5C10 unconjugated
anti-Retinitis Pigmentosa 2 (X-Linked Recessive) (RP2) (AA 251-350) antibodyRP2 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 1B4 unconjugated
anti-Retinitis Pigmentosa 2 (X-Linked Recessive) (RP2) (AA 1-350) antibodyRP2 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Retinitis Pigmentosa 2 (X-Linked Recessive) (RP2) (AA 1-350) antibodyRP2 Reaktivität: Human WB, ELISA, IHC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Retinitis Pigmentosa 2 (X-Linked Recessive) (RP2) (C-Term) antibodyRP2 Reaktivität: Human, Maus, Ratte, Hund, Kaninchen, Hamster WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Retinitis Pigmentosa 2 (X-Linked Recessive) (RP2) (AA 1-350) antibodyRP2 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Retinitis Pigmentosa 2 (X-Linked Recessive) (RP2) (Middle Region) antibodyRP2 Reaktivität: Human, Maus, Ratte, Hund, Kaninchen, Rind (Kuh), Meerschweinchen, Pferd WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- RP2 (Retinitis Pigmentosa 2 (X-Linked Recessive) (RP2))
-
Andere Bezeichnung
- RP2
-
Pathways
- Nucleotide Phosphorylation, Ribonucleoside Biosynthetic Process
Target
-
